In contrast to the role of RIPK1 as a central regulator of immune tolerance in PDA, the decreased expression of RIPK3 in macrophages associated with HCC correlated with tumorigenesis as observed in both murine models and human samples. The gene discussed is RIPK1; the disease is Patent ductus arteriosus.